Agendia has tapped Al Luderer to serve on its supervisory board. Luderer is CEO of BioTrove, and he is on the scientific advisory board at Washington University's Department of Biomedical Engineering. He formerly was CEO of Light Sciences Corporation, and he has been chief operating officer at BioMerieux. He also previously served as vice president of technology development and support at Boehringer Mannheim.
Enzo Biochem has appointed Kevin Krenitsky as president of its Enzo Clinical Labs subsidiary.
Prior to joining Enzo Clinical Labs, Krenitsky was CEO of Bioserve Biotechnologies. Previous to Bioserve, he was CEO of Parkway Clinical Laboratories. He also served as senior vice president and division head at SeraCare Life Sciences’ Genomics Collaborative Division.
Krenitsky holds an MD from Jefferson Medical College.